Jennifer A. Yoon advises clients across the life sciences industry on complex corporate and securities law matters.
Jennifer combines extensive transactional experience and a client-first approach to guide biotechnology and other life sciences companies at every stage of maturity through:
- Public offerings, including initial public offerings (IPO), follow-on offerings, at-the-market offerings, and private investments in public entities
- Securities law compliance and public company representation
- Corporate governance and strategy for early-stage companies
- Preferred equity financings for early-stage companies
She keenly understands the capital markets implications for life sciences companies and distills complex scientific and legal jargon into actionable client advice. Jennifer develops trusted, long-term relationships to both help clients navigate high-stakes transactions and strategize solutions to day-to-day corporate issues that arise.
A recognized leader at the firm, Jennifer serves on the Ethics Committee and previously served on the Associates Committee.
Before her legal career, Jennifer was a children’s book editor.